Senior Oncology MSL, Cape Town - Field-Based

Placements24; Cape Town; Sur place; ZAR 1 200 000 - 1 800 000; Plein temps

Avantages offerts par ce poste

Medical and dental insurance

Retirement savings plan

Professional development opportunities

Résumé du poste

Placements24 is seeking a Lead Medical Science Liaison to cover Cape Town, Western Cape. The role acts as the scientific interface with KOLs, investigators, and healthcare professionals in oncology, disseminating complex data and identifying collaboration opportunities.

The ideal candidate will hold an advanced degree (MD/PhD/PharmD or equivalent) with 7+ years in pharma/biotech, including 5+ years as an MSL.

Qualifications

• Advanced degree in a scientific or medical discipline.
• Minimum 7 years pharma/biotech experience; 5+ years in an MSL role.
• Deep oncology knowledge and KOL network.
• Strong presentation and communication skills.
• Ability to travel extensively within the Cape Town region and beyond.

Responsabilités

• Establish and maintain relationships with KOLs, investigators, and healthcare providers in oncology.
• Deliver scientific and clinical information on products and pipeline.
• Facilitate investigator-initiated studies and support trial recruitment.
• Provide feedback to R&D on clinical trials and scientific strategy.
• Present data at advisory boards, symposia, and meetings.
• Ensure compliance with regulations and company policies.

Connaissances

KOL engagement

Scientific communication

Advisory board presentation

Cross-functional collaboration

Travel readiness

Formation

MD/PhD/PharmD or equivalent

Description du poste

Placements24 is seeking a Lead Medical Science Liaison to cover Cape Town, Western Cape. The role acts as the scientific interface with KOLs, investigators, and healthcare professionals in oncology, disseminating complex data and identifying collaboration opportunities.

The ideal candidate will hold an advanced degree (MD/PhD/PharmD or equivalent) with 7+ years in pharma/biotech, including 5+ years as an MSL.